![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » THE MAXXON REVAC SAFETY SYRINGE ACTIVATION FORCE LAB STUDY COMPLETED AND DESIGN WORK FINALIZED
THE MAXXON REVAC SAFETY SYRINGE ACTIVATION FORCE LAB STUDY COMPLETED AND DESIGN WORK FINALIZED
June 15, 2006
Maxxon, Inc., a growing medical products designer, manufacturer, and distributor concentrating on innovative Safety-engineered medical devices (SEMDs) that will have a price advantage over many competitors in the SEMDs arena, announces the results of Globe Med Tech's optimum retraction activation force user/lab study for its Maxxon 3 cc Vacuum Operated Retractable Safety Syringe plunger. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-15-2006/0004381280&EDATE=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct